Apogee Therapeutics is now part of AbbVie
Public source
Publisher name
Public post
Apogee Therapeutics is now part of AbbVie. Learn more: https://lnkd.in/gK2yeCC6
Company
Apogee Therapeutics
- Industry
- Biotechnology Research
- Location
- Fully Remote, US
- Company size
- 201–500 employees
About Apogee Therapeutics
Apogee Therapeutics is now part of AbbVie. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
AbbVie
AbbVie acquired Apogee Therapeutics, a company focused on elevating the standard of care for patients with dermatologic, respiratory and other related inflammatory and immunological diseases.
Strategy & Corporate Development
Merida Biosciences
Merida Biosciences entered into a definitive agreement to be acquired by Eli Lilly and Company to advance treatments for serious autoimmune and allergic diseases.
Strategy & Corporate Development
Myricx Bio
Myricx Bio became a Novartis Company following a transaction valued at up to $1.5 billion including $1.1 billion cash up front.
Strategy & Corporate Development
Portal Innovations
Portal Innovations acquired the Portal portfolio company CrossBridge Bio for up to $300 million.
Strategy & Corporate Development
AB BIOTECHNOLOGY LIMITED